These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 6237664)

  • 21. Defective NK cell activity following thermal injury.
    Klimpel GR; Herndon DN; Fons M; Albrecht T; Asuncion MT; Chin R; Stein MD
    Clin Exp Immunol; 1986 Nov; 66(2):384-92. PubMed ID: 3493101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhancement of susceptibility of HSV-1-infected cells to natural killer lysis by interferon.
    Muñoz A; Carrasco L; Fresno M
    J Immunol; 1983 Aug; 131(2):783-7. PubMed ID: 6190939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Augmentation of autologous tumor killing activity of tumor-associated large granular lymphocytes by the streptococcal preparation OK432.
    Uchida A
    Methods Find Exp Clin Pharmacol; 1986 Feb; 8(2):81-4. PubMed ID: 2423823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interferon-beta and recombinant IL 2 can both enhance, but by different pathways, the nonspecific cytolytic potential of T3- natural killer cell-derived clones rather than that of T3+ clones.
    van de Griend RJ; Ronteltap CP; Gravekamp C; Monnikendam D; Bolhuis RL
    J Immunol; 1986 Mar; 136(5):1700-7. PubMed ID: 3005399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative analysis of natural killer function in lung, spleen, and peripheral blood lymphocytes: evidence of differential characteristics.
    Lauzon W; Yang H; Lemaire I
    Reg Immunol; 1990-1991; 3(3):145-50. PubMed ID: 2129104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of a streptococcal preparation (OK432) on natural killer activity of tumour-associated lymphoid cells in human ovarian carcinoma and on lysis of fresh ovarian tumour cells.
    Colotta F; Rambaldi A; Colombo N; Tabacchi L; Introna M; Mantovani A
    Br J Cancer; 1983 Oct; 48(4):515-25. PubMed ID: 6626452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of natural killer cytotoxicity by recombinant alpha interferons. Augmentation by IFN-alpha 7, an interferon similar to IFN-alpha J.
    Platsoucas CD; Fox FE; Oleszak E; Fong K; Nanno M; Ioannides CG; Trotta PP
    Anticancer Res; 1989; 9(4):849-58. PubMed ID: 2817813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction by interferon-alpha of tumoricidal activity of adherent mononuclear cells from human blood: monocytes as responder and effector cells.
    Sone S; Utsugi T; Shirahama T; Ishii K; Mutsuura S; Ogawara M
    J Biol Response Mod; 1985 Apr; 4(2):134-40. PubMed ID: 3998764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systemic administration of human leukocyte interferon to melanoma patients. II. Cellular events associated with changes in natural killer cytotoxicity.
    Golub SH; D'Amore P; Rainey M
    J Natl Cancer Inst; 1982 May; 68(5):711-7. PubMed ID: 6175788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Strong natural killer (NK) cell activity in bone marrow of myeloma patients: accelerated maturation of bone marrow NK cells and their interaction with other bone marrow cells.
    Uchida A; Yagita M; Sugiyama H; Hoshino T; Moore M
    Int J Cancer; 1984 Sep; 34(3):375-81. PubMed ID: 6592156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of natural killer cell cytotoxicity of cancer patients treated with recombinant interferon.
    Lotzová E; Savary CA; Quesada JR; Gutterman JU; Hersh EM
    J Natl Cancer Inst; 1983 Nov; 71(5):903-10. PubMed ID: 6580490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 2',5'-Oligoadenylate trimer core and the cordycepin analog augment the tumoricidal activity of human natural killer cells.
    Black PL; Henderson EE; Pfleiderer W; Charubala R; Suhadolnik RJ
    J Immunol; 1984 Nov; 133(5):2773-7. PubMed ID: 6332860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low doses of interferon alpha result in more effective clinical natural killer cell activation.
    Edwards BS; Merritt JA; Fuhlbrigge RC; Borden EC
    J Clin Invest; 1985 Jun; 75(6):1908-13. PubMed ID: 4008643
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intrapleural administration of OK432 in cancer patients: activation of NK cells and reduction of suppressor cells.
    Uchida A; Micksche M
    Int J Cancer; 1983 Jan; 31(1):1-5. PubMed ID: 6219961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.
    Wiebke EA; Custer MC; Rosenberg SA; Lotze MT
    J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Induction of human monocyte-mediated tumor cell killing by alpha or beta interferon].
    Utsugi T; Mutsuura S; Ogawara M; Shirahama T; Ishii K; Tsubura E; Sone S
    Gan To Kagaku Ryoho; 1985 May; 12(5):1105-10. PubMed ID: 3994398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interferon effect on cytotoxicity of peripheral blood and tumor-associated lymphocytes against human ovarian carcinoma cells.
    Allavena P; Introna M; Sessa C; Mangioni C; Mantovani A
    J Natl Cancer Inst; 1982 Apr; 68(4):555-62. PubMed ID: 6175786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of murine natural killer cell activity in vitro and in vivo by recombinant human interferons.
    Brunda MJ; Rosenbaum D
    Cancer Res; 1984 Feb; 44(2):597-601. PubMed ID: 6692364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protection of cultured human monocytes from lymphokine-activated killer-mediated lysis by IFN-gamma.
    Blanchard DK; Djeu JY
    J Immunol; 1988 Dec; 141(11):4067-73. PubMed ID: 2460557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic differences in the age-associated decrease in inducibility of natural killer cells by interferon-alpha/beta.
    Plett A; Murasko DM
    Mech Ageing Dev; 2000 Jan; 112(3):197-215. PubMed ID: 10687925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.